Concentra Group Holdings Parent, Inc., the Services sector company, was revisited by a Wall Street analyst today. Analyst Stephen Baxter from Wells Fargo maintained a Buy rating on the stock and has a $25.00 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Stephen Baxter has given his Buy rating due to a combination of factors including the encouraging Q2 results reported by Concentra Group Holdings Parent, Inc. The company showed improvement in organic volume growth trends in both workers’ compensation and employer services, despite the challenging macroeconomic environment. This positive performance led to a modest increase in earnings estimates, while the price target remains at $25.
Additionally, Concentra’s raised EBITDA guidance for 2025, now ranging from $420 million to $430 million, reflects confidence in maintaining organic volume trends similar to year-to-date performance. The company also benefits from macro stability and positive employer services visit growth, while being minimally impacted by federal legislation. These factors collectively support the Buy rating assigned by Stephen Baxter.
Baxter covers the Healthcare sector, focusing on stocks such as UnitedHealth, Centene, and Molina Healthcare. According to TipRanks, Baxter has an average return of -6.2% and a 36.54% success rate on recommended stocks.
In another report released on August 11, Truist Financial also reiterated a Buy rating on the stock with a $29.00 price target.